SPEED MCQUEEN
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99257173
- Mark type
- Stylized text
- Filed
- 27 Jun 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable database in the field of scientific research and development featuring information relating to chemical compounds
- Class 042 — Scientific and technological services: Scientific research services in the field of chemistry; providing an online computer database in the field of scientific research and development featuring information relating to chemical compounds; scientific research services involving the analysis and characterization of chemical properties in biological samples for research purposes; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract scientific research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in the field of scientific research and development in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; Scientific and technological services, namely, scientific research and design for others in the field of pharmaceuticals and conducting and evaluating clinical trials for others; software as a service (SaaS) services featuring software for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing data, and developing pharmaceutical products and chemical compounds
Owner
- Enveda Therapeutics, Inc., Boulder, CO, US
- Enveda Therapeutics, Inc., Boulder, CO, US
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Nov 2025 — NON-FINAL ACTION E-MAILED
- 17 Nov 2025 — NON-FINAL ACTION WRITTEN
- 17 Nov 2025 — ASSIGNED TO EXAMINER
- 04 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Jun 2025 — NEW APPLICATION ENTERED